Assessing kidney function by measuring glomerular filtration rate and urinary albumin levels can help determine which patients with chronic kidney disease (CKD) will develop end-stage renal disease (ESRD), according to a study published in the May 2009 issue of the Journal of the American Society Nephrology. This combination test could help physicians to identify patients at high risk of serious kidney trouble and allow them to intervene at an early stage.

Subscribers: click here for the full story

Non-Subscribers: click here to subscribe

June 2009 - Table of Contents

DTTR June 2009

H1N1 Outbreak Puts Focus on Lab Testing Capability

ACLU Suit Challenges Breast Cancer Gene Patents

Nanogen Files for Chapter 11, Agrees to Sell Assets

Myriad Sees MDx Revenues Rise 47%, Launches Seventh Test

Inside the Diagnostics Industry: FDA Clears CDC Test for H1N1, Companies Race to Develop Own Tests

CMS Proposal Would Limit Medicare Coverage for Warfarin Response Testing

Combination Test Can Predict End-Stage Renal Disease

JAMA Study Links Albumin Levels to Blood Clot Risk

Genetix Acquires SlidePath to Expand in Digital Pathology

Thermo Fisher to Acquire Alesco’s Biolab Division for $120 Million

Prometheus Partners With Rosetta Genomics on Molecular Tests for Cancer

‘Comparative Effectiveness’ Is New Buzzword in Washington

IVD Stocks Up 6%; Quidel Soars 43% on Swine Flu Outbreak

G-2 Insider: Personnel Changes at FDA